Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry

World Journal of Gastroenterology

Volumn 11, Issue 30, 2005, Pages 4679-4684

  Zhang, Ying Tao ^a   Geng, Yi Ping ^a   Zhou, Le ^a   Lai, Bao Chang ^a   Si, Lv Sheng ^a   Wang, Yi Li ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; MALDI TOF MS; Peptide mass fingerprinting; SW480 cell line; Two dimensional electrophoresis

Indexed keywords

BINDING PROTEIN; ENOLASE; MYC PROTEIN; ONCOPROTEIN; SILVER NITRATE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRYPSIN; ZINC FINGER PROTEIN;

ARTICLE; CARCINOMA CELL; CELL CULTURE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; COMPUTER PROGRAM; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PH; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN IMMOBILIZATION; PROTEOMICS; RANDOMIZATION; STAINING; SWISS-PROT; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 23844550776     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i30.4679     Document Type: Article

References (25)

1. Crawford NP, Colliver DW, Galandiuk S. Tumor markers and colorectal cancer: utility in management. J Surg Oncol 2003; 84: 239-248
2. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, Ollendorff V, Fert V, Giovaninni M, Delpero JR, Nguyen C, Viens P, Monges G, Birnbaum D, Houlgatte R. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004; 23: 1377-1391
3. Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 2001; 70: 437-473
4. Long YZ, Fan XG, Li N. Progress in tumor proteomics. Shijie Huaren Xiaohua Zazhi 2002; 10: 1436-1440
5. Katayama H, Nagasu T, Oda Y. Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2001; 15: 1416-1421
6. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422: 198-207
7. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons. Anal Chem 1988; 60: 2299-2301
8. Berndt P, Hobohm U, Langen H. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 1999; 20: 3521-3526
9. Thoden JB, Taylor Ringia EA, Garrett JB, Gerlt JA, Holden HM, Rayment I. Evolution of enzymatic activity in the enolase superfamily: structural studies of the promiscuous osuccinylbenzoate synthase from amycolatopsis. Biochemistry 2004; 43: 5716-5727
10. Herzig KH, Altmannsberger M, Folsch UR. Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 1994; 106: 1326-1332
11. Jiang GL, Huang S. The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 2000; 15: 109-117
12. Cabrera T, Lopez-Nevot MA, Gaforio JJ, Ruiz-Cabello F, Garrido F. Analysis of HLA expression in human tumor tissues. Cancer Immunol Immunother 2003; 52: 1-9
13. Edelshtein D, Sidebottom D, Chen DF, Baxter-Lowe LA. A novel HLA-DPB1 allele identified by sequence-based typing and confirmed by SSP. Hum Immunol 2003; 64(10 Suppl): S162
14. Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, Parodi AM, Sergeant R, Martinetti M, Bontadini A, Bonifazi F, Lisini D, Mazzi B, Rossini S, Servida P, Ciceri F, Bonini C, Lanino E, Bandini G, Locatelli F, Apperley J, Bacigalupo A, Ferrara GB, Bordignon C, Fleischhauer K. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004; 103: 1417-1424
15. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4: 336-347
16. Ryu KS, Lee YS, Kim BK, Park YG, Kim YW, Hur SY, Kim TE, Kim IK, Kim JW. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers. Exp Mol Med 2001; 33: 136-144
17. Cabrera T, Collado A, Fernandez MA, Ferron A, Sancho J, Ruiz-Cabello F, Garrido F. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens 1998; 52: 114-123
18. Palmisano GL, Pistillo MP, Capanni P, Pera C, Nicolo G, Salvi S, Perdelli L, Pasciucco G, Ferrara GB. Investigation of HLA class I downregulation in breast cancer by RT-PCR. Hum Immunol 2001; 62: 133-139
19. Redondo M, Garcia J, Villar E, Rodrigo I, Perea-Milla E, Serrano A, Morell M. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis. Hum Pathol 2003; 34: 1283-1289
20. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995; 16: 487-494
21. Marincola FM, Ferrone S. Immunotherapy of melanoma: the good news, the bad ones and what to do next. Semin Cancer Biol 2003; 13: 387-389
22. Cabrera T, Salinero J, Fernandez MA, Garrido A, Esquivias J, Garrido F. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol 2000; 61: 499-506
23. Atkins D, Ferrone S, Schmahl GE, Storkel S, Seliger B. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol 2004; 171: 885-859
24. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301-306
25. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101: 455-458